Replies to post #411944 on Anavex Life Sciences Corp (AVXL)

[Kb1123]

Part of Misslings job is to attract investors. He has made a lot of bold comments about the potential of A273 and the rest of the pipeline. Most of Misslings predictions have yet to come to fruition. I’ve come to the conclusion that Missling was doing his job. Saying things that attracted investors. Unfortunately it was mostly retail investors that believed his comments. So it’s not Misslings fault for blowing smoke it’s the investors fault for taking him at his word and not selling when they had the chance.

[abew4me]

You're kidding, right?

How can a biotech company generate revenue when it takes approximately 10+ years to get a drug approved?

Dr. Missling is approaching his 10 year anniversary here and A2-73 should be approved within the next 6 - 12 months...which is the norm for any new drug.

If you can't understand that, then you shouldn't be invested in biotech. It's that simple.

[crescentmotor]

in the last.10 years, how much revenue has the company generated?

None--just as anyone would expect from a developmental stage company in the biotech sector where it generally takes ten years and $1 billion to take a drug from preclinical stage to commercialization.